The ¦Ã-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates A¦Â1-42 seeding and short-term memory deficits in the A¦Â25-35 mouse model of Alzhei
文摘
Alzheimer's disease pathomimetic toxicity could be induced in mice within one week after the intracerebroventricular (i.c.v.) injection of an aggregated preparation of the highly toxic and endogenous amyloid-¦Â fragment A¦Â25-35. It was recently reported that A¦Â25-35 also provokes a modification of APP processing with accumulation of endogenous A¦Â1-42. We here analyzed whether a ¦Ã-secretase inhibitor, BMS-299897, attenuated this A¦Â25-35-induced A¦Â1-42 seeding and toxicity. The compound was administered at 0.1-1 nmol/mouse, concomittantly with A¦Â25-35 (9 nmol) in male Swiss mice. After one week, the contents in A¦Â1-42 and A¦Â1-40, and the levels in lipid peroxidation were analyzed in the mouse hippocampus. Mice were submitted to spontaneous alternation, passive avoidance and object recognition to analyze their short- and long-term memory abilities. A¦Â25-35 increased A¦Â1-42 content (+240 % ) but failed to affect A¦Â1-40. BMS-299897 blocked the increase in A¦Â1-42 content and decreased A¦Â1-40 levels significantly. The compound did not affect A¦Â25-35-induced increase in hippocampal lipid peroxidation. Behaviorally, BMS-299897 blocked the A¦Â25-35-induced deficits in spontaneous alternation or novel object recognition, using a 1 h intertrial time interval. BMS-299896 failed to affect the passive avoidance impairments or novel object recognition, using a 24 h intertrial time interval. These results confirmed that A¦Â25-35 injection provoked an accumulation in endogenous A¦Â1-42, an effect blocked by ¦Ã-secretase inhibition. This A¦Â1-42 accumulation marginally contributed to the toxicity or long-term memory deficits. However, since the seeded A¦Â1-42 affected short-term memory, the rapid A¦Â25-35 injection Alzheimer's disease model could be used to screen the activity of new secretase inhibitors.